THYROID CANCER RECURRENT

This adverse event was reported 117 times

These drugs are most commonly taken by patients reporting THYROID CANCER RECURRENT:

# Drug Count
0 LEVOTHYROXINE SODIUM 28
1 ALPRAZOLAM 9
2 METFORMIN 9
3 METFORMIN ER 500 MG 9
4 METFORMIN ER 750 MG 9
5 OMEPRAZOLE MAGNESIUM 9
6 ADALIMUMAB 8
7 OMEPRAZOLE 8
8 ALBUTEROL SULFATE 7
9 METHOTREXATE 7
See all common drugs associated with THYROID CANCER RECURRENT

THYROID CANCER RECURRENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Thyroid Stimulating Hormone [EPC] 3 0.0029
1 Interleukin-5 Antagonist [EPC] 1 0.0015
2 Guanylate Cyclase-C Agonist [EPC] 2 0.0010
3 Provitamin D2 Compound [EPC] 7 0.0002
4 Barbiturate [EPC] 2 0.0002
5 Interleukin-17A Antagonist [EPC] 4 0.0001
6 Vitamin D3 Analog [EPC] 2 0.0001
7 Human Immunoglobulin G [EPC] 2 0.0001
8 Anti-anginal [EPC] 1 0.0001
9 Aluminum Complex [EPC] 2 0.0001
See all drug classes enriched for association with THYROID CANCER RECURRENT